A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Aminex Therapeutics, Inc.
Shenzhen BinDeBio Ltd.
Laboratorio Elea Phoenix S.A.
INSYS Therapeutics Inc